compounded semaglutide lawsuit Drug compounders sue FDA over declaration ending Wegovy shortage Novo Nordisk drops lawsuit against
Description
Do not use the pen if the medication is discolored, or if you notice particles in it
Retatrutide at a glance Not approved research chemical Type Investigational drug in clinical trials, not yet approved Also called LY3437943 Interest in it for Obesity / weight loss and type 2 diabetes Evidence Human clinical trials underway
Some patients respond excellently to higher-dose semaglutide or microdose protocols
The demonstrated benefits span fat reduction, blood sugar control, cardiovascular risk markers, liver fat reduction, and joint pain relief
Lower-tier drugs tend to have cheaper copays than higher-tier drugs
No worsening of spinal CSF leak symptoms : Given the research I recap below about intracranial hypertension and use of GLP-1RAs to lower intracranial pressure, I was very concerned that this class of medication could worsen my spinal CSF leak symptoms
